Breaking
Secure Stock Strategies
Author

admin

Browsing
Politics

Republicans torch anti-Trump ‘No Kings’ protests, say Dems fear angering leftists in shutdown fight

Republican lawmakers have spent the week sharpening their attacks on Saturday’s nationwide day of protests against President Donald Trump, which many GOP leaders dismissed as ‘Hate America’ rallies.

Cities across the country are expected to see hundreds of thousands of people come out for the ‘No Kings’ movement, and several congressional Democrats have even said they will attend.

Republicans have seized on the protests as a product of far-left activism, while at the same time arguing Democrats have held firm against the GOP’s plan to end the government shutdown in a bid to please that far-left base.

House Speaker Mike Johnson, R-La., told Fox Business Network he hoped that Democratic leaders who attended would be more willing to accept the GOP’s plan after the demonstrations were over — but he did not sound overly optimistic.

‘It’ll be a collection of wild leftist policy priorities, and that’ll be on display for the whole country. After that’s over, I hope there’s a few Democrats over here who will come to their senses and return to governing the country,’ Johnson said.

‘Right now, I don’t think— it’s my assumption and all of ours that they would not make that concession before that rally’s over because they don’t want to face the angry mob. I mean it’s sad, but that’s where we are.’

House Minority Leader Hakeem Jeffries, D-N.Y., dodged a question on whether he would attend one of the rallies on Friday, telling reporters, ‘I haven’t finalized my schedule for the weekend given, you know, the sensitivities around the government shutdown. I’m still very hopeful that Republicans will decide to show up for work so we can get the government back open.’

‘But I support the right of every single American to participate in the rallies that are going to take place this week and showing up to express dissent against an out-of-control administration,’ he said.

However, Senate Minority Leader Chuck Schumer, D-N.Y., said he would attend one of the protests, as did House Democratic Caucus Chairman Pete Aguilar, D-Calif.

Rep. Zach Nunn, R-Iowa, predicted more top Democratic figures would go but, like Johnson, signaled hope that they would acquiesce to Republicans’ demands when it was over.

‘My guess is if they don’t want a primary from the left, they’ll probably find a way to sneak it into their schedule. The real question that’s going to be is, do they have the fortitude after Saturday to come back and open up the government?’ Nunn told Fox News Digital earlier this week.

‘They should be doing it today. But if they feel like they’ve got to appease their base, then they better come to Jesus on Sunday and figure out a way to help them get back to the business of taking care of the American people.’

House GOP leaders also criticized the rallies at nearly every one of their daily shutdown press conferences this week.

Majority Leader Steve Scalise, R-La., said Friday that Schumer was ‘more concerned’ with ‘impressing the ‘Hate America’ rally crowd that’s coming up here tomorrow than he is about not solving all of our problems tomorrow.’

And House Majority Whip Tom Emmer, R-Minn., told Fox News’ Maria Bartiromo on Tuesday of the rallies’ place in the shutdown fight, ‘The rumor is that they can’t end the shutdown beforehand, because a small but very violent and vocal group is the only one that’s happy about this.’

‘If they shut it down beforehand, then they’ve got to deal with that group beforehand. If they make it through that, then at least they’ve made it through their Hate America rally, and then they can get this thing done,’ Emmer said.

The House passed a bill to keep the federal government funded at current levels through Nov. 21, called a continuing resolution (CR), mostly along party lines last month.

It’s since failed 10 times in the Senate, with a majority of Democrats rejecting any spending deal that does not also include an extension of COVID-19 pandemic-era Obamacare subsidies that will expire at the end of this year without congressional action.

This post appeared first on FOX NEWS

Keep Reading
By
Investing

CHARBONE annonce un financement de reglements de dettes par emission d’unites totalisant 0,5M$

(TheNewswire)

Brossard, Quebec, le 17 octobre 2025 TheNewswire – CORPORATION CHARBONE (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (« CHARBONE » ou la « Société »), un producteur et distributeur nord-américain spécialisé dans l’hydrogène propre à Ultra Haute Pureté (« UHP ») et les gaz industriels stratégiques, a le plaisir d’annoncer la clôture de règlements de dettes par émission d’unités s’élevant à 503 125 $ avec un partenaire stratégique pour la construction de l’usine de Sorel-Tracy.

La Société a conclu 503 125 $ de comptes à payer avec un fournisseur sans lien de dépendance par l’émission d’unités. Chaque unité offerte, au prix de 0,12 $ l’unité, comprenait une action ordinaire de la Société et un bon de souscription d’action ordinaire . Chaque bon de souscription permettra à son porteur d’acquérir une action ordinaire supplémentaire de la Société à un prix d’exercice de 0,14 $ pendant 12 mois après la date de clôture. Un total de 4 192 708 d’unités seront émises à la clôture, au prix de conversion unitaire de 0,12 $. La Société estime que le règlement de ses dettes par l’émission de titres est approprié pour faire progresser la production de son projet à Sorel-Tracy et pour gérer sa trésorerie avec prudence. Une entente officielle reflétera tout règlement de dette et sera assujetti à l’approbation de la Bourse de croissance TSX. Tous titres émis dans le cadre de ce règlement de dettes sera assujetti à la période de détention légale au Canada de quatre mois

À propos de CORPORATION CHARBONE

CHARBONE est une entreprise intégrée spécialisée dans l’hydrogène propre à Ultra Haute Pureté (UHP) et la distribution stratégique de gaz industriels en Amérique du Nord et en Asie-Pacifique. Elle développe un réseau modulaire de production d’hydrogène vert tout en s’associant à des partenaires de l’industrie pour offrir de l’hélium et d’autres gaz spécialisés sans avoir à construire de nouvelles usines coûteuses. Cette stratégie disciplinée diversifie les revenus, réduit les risques et augmente sa flexibilité. Le groupe Charbone est coté en bourse en Amérique du Nord et en Europe sur la bourse de croissance TSX (TSXV: CH,OTC:CHHYF) ; sur les marchés OTC (OTCQB: CHHYF) ; et à la Bourse de Francfort (FSE: K47) . Pour plus d’informations, visiter www.charbone.com .

Énoncés prospectifs

Le présent communiqué de presse contient des énoncés qui constituent de « l’information prospective » au sens des lois canadiennes sur les valeurs mobilières (« déclarations prospectives »). Ces déclarations prospectives sont souvent identifiées par des mots tels que « a l’intention », « anticipe », « s’attend à », « croit », « planifie », « probable », ou des mots similaires. Les déclarations prospectives reflètent les attentes, estimations ou projections respectives de la direction de Charbone concernant les résultats ou événements futurs, sur la base des opinions, hypothèses et estimations considérées comme raisonnables par la direction à la date à laquelle les déclarations sont faites. Bien que Charbone estime que les attentes exprimées dans les déclarations prospectives sont raisonnables, les déclarations prospectives comportent des risques et des incertitudes, et il ne faut pas se fier indûment aux déclarations prospectives, car des facteurs inconnus ou imprévisibles pourraient faire en sorte que les résultats réels soient sensiblement différents de ceux exprimés dans les déclarations prospectives. Des risques et des incertitudes liés aux activités de Charbone peuvent avoir une incidence sur les déclarations prospectives. Ces risques, incertitudes et hypothèses comprennent, sans s’y limiter, ceux décrits à la rubrique « Facteurs de risque » dans la déclaration de changement à l’inscription de la Société datée du 31 mars 2022, qui peut être consultée sur SEDAR à l’adresse www.sedar.com; ils pourraient faire en sorte que les événements ou les résultats réels diffèrent sensiblement de ceux prévus dans les déclarations prospectives.

Sauf si les lois sur les valeurs mobilières applicables l’exigent, Charbone ne s’engage pas à mettre à jour ni à réviser les déclarations prospectives.

Ni la Bourse de croissance TSX ni son fournisseur de services de réglementation (tel que ce terme est défini dans les politiques de la Bourse de croissance TSX) n’acceptent de responsabilité quant à la pertinence ou à l’exactitude du présent communiqué.

Pour contacter Corporation Charbone :

Téléphone bureau: +1 450 678 7171

Courriel: ir@charbone.com

Benoit Veilleux

Chef de la direction financière et secrétaire corporatif

Copyright (c) 2025 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
By
Investing

FALCO ANNOUNCES CLOSING OF BOUGHT DEAL PRIVATE PLACEMENT

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

TSX.V – FPC

 Falco Resources Ltd. (TSXV: FPC,OTC:FPRGF) (‘Falco’ or the ‘Corporation’) is pleased to announce the closing of its previously announced bought deal private placement (the ‘Offering’) with a syndicate of underwriters led by Cantor Fitzgerald Canada Corporation, acting as lead agent and sole bookrunner, and including BMO Nesbitt Burns Inc., National Bank Financial Inc. and Canaccord Genuity Corp. (collectively, the ‘Underwriters’). Pursuant to the Offering, Falco has issued an aggregate of 41,005,000 units of the Corporation (the ‘Units’) at a price of $0.32 per Unit, for aggregate gross proceeds of $13,121,600.

Each Unit consists of one common share (each, a ‘Common Share‘) of the Corporation and one-half of one common share purchase warrant (each whole warrant, a ‘Warrant‘). Each Warrant is exercisable to acquire one Common Share at a price of C$0.46 at any time on or before April 17, 2027.

The Corporation intends to use the net proceeds from the sale of Units for the advancement of the Horne 5 Project and for working capital and general corporate purposes.

In connection with the closing of the Offering, the Underwriters received an aggregate cash fee equal to $787,296.

All Common Shares and Warrants issued pursuant to the Offering are subject to a hold period of four months plus one day from the date of issuance of such securities under applicable securities laws in Canada.

Related parties of the Corporation, including Osisko Development Corp. and certain directors and officers of the Corporation, subscribed for an aggregate of 7,455,000 Units such that the Offering constitutes a ‘related party transaction’ within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (‘MI 61-101‘). The Corporation is relying on exemptions from the formal valuation requirements of MI 61-101 pursuant to section 5.5(a) and the minority shareholder approval requirements of MI 61-101 pursuant to section 5.7(1)(a) in respect of such related party participation as the fair market value of the transaction, insofar as it involves interested parties, does not exceed 25% of the Corporation’s market capitalization. Additional information with respect thereto will be published in a material change report to be filed by the Corporation following the closing of the Offering. The Corporation did not file the material change report 21 days prior to closing of the Offering, as the related parties’ participation had not been confirmed at that time and the Corporation wished to close the transaction as soon as practicable for sound business reasons.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements thereunder.

About Falco

Falco is one of the largest mineral claim holders in the province of Québec, with an extensive portfolio of properties in the Abitibi-Témiscamingue greenstone belt. Falco holds rights to approximately 67,000 hectares of land in the Noranda Mining Camp, which represents 67% of the camp as a whole and includes 13 former gold and base metal mining sites. Falco’s main asset is the Horne 5 project located beneath the former Horne mine, which was operated by Noranda from 1927 to 1976 and produced 11.6 million ounces of gold and 2.5 billion pounds of copper. Osisko Development Corp. is Falco’s largest shareholder, with a 16% interest in the Corporation.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Statement on Forward-Looking Information

This news release contains forward-looking statements and forward-looking information (together, ‘forward looking statements’) within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by words such as ‘plans’, ‘expects’, ‘seeks’, ‘may’, ‘should’, ‘could’, ‘will’, ‘budget’, ‘scheduled’, ‘estimates’, ‘forecasts’, ‘intends’, ‘anticipates’, ‘believes’, or variations including negative variations thereof of such words and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved. These statements are made as of the date of this news release. Forward-looking statements in this press release include, without limitation, the use of proceeds of the Offering. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the risk factors set out in Falco’s annual and/or quarterly management discussion and analysis and in other of its public disclosure documents filed on SEDAR+ at www.sedarplus.ca, as well as all assumptions regarding the foregoing. Although the Corporation believes the forward-looking statements in this news release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. Consequently, the Corporation cautions investors that any forward-looking statements by the Corporation are not guarantees of future results or performance and that actual results may differ materially from those in forward-looking statements.

SOURCE Falco Resources Ltd.

View original content: http://www.newswire.ca/en/releases/archive/October2025/17/c3356.html

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
By
Investing

Titan on Track for New York Graphite Production as US Pushes for Domestic Supply Chain

Titan Mining (TSX:TI,OTCQB:TIMCF) is on track to start producing natural graphite concentrate at its Empire State operation in Gouverneur, New York, positioning itself as the first near-term US supplier.

“China’s decision to tighten graphite exports underscores the importance of having a secure domestic supply of natural graphite,” said Titan President and CEO Rita Adiani in a Tuesday (October 14) release. “Natural graphite touches every strategic sector — from defense to energy to AI data centers — and the U.S. currently produces none of it.

“Titan is changing that by re-establishing natural flake graphite production and high-purity graphite processing here at home to support the technologies and systems that keep America strong,” she added.

Titan’s integrated demonstration facility will process material from the company’s wholly owned Kilbourne deposit, which is adjacent to the Empire State operation. The program is designed to validate commercial-scale recoveries and produce offtake samples for US and allied industrial, defense and energy customers.

Commissioning of the facility is expected this quarter, with customer qualification in Q1 2026.

If the demonstration phase is successful, Titan’s plan is for a commercial-scale facility to eventually ramp up to 40,000 metric tons per year, which is enough to meet roughly half of current US natural graphite demand.

The announcement from Titan comes as China, which dominates global graphite supply, expands its export controls on key materials. In recent months, Beijing has imposed new restrictions on artificial graphite and blended anode materials under MOFCOM Announcement No. 58 (2025); it has put similar curbs on rare earths.

The measures are expected to further strain global feedstock availability for electric vehicle and battery manufacturing, intensifying pressure on western countries to develop their own supply chains.

Titan’s move also coincides with growing US government efforts to rebuild domestic capacity in critical minerals.

In August, the Department of Energy announced nearly US$1 billion in new funding opportunities to boost mining and processing of such minerals, including graphite. A recent study from the University of Michigan found that the US holds enough natural graphite reserves — over 7 million metric tons — to meet projected demand through 2040.

However, the research underscores major economic and quality hurdles.

“Currently, China dominates the global supply of graphite and there are concerns about supply chain security,” said Gregory Keoleian, professor at the University of Michigan School for Environment and Sustainability.

While US deposits are sufficient, they are of lower grade than those found abroad, making domestic production costlier. Despite these challenges, the researchers argue that US production could deliver both climate and strategic benefits.

“We also looked at the carbon footprint of graphite and it’s likely that there would be a decrease in greenhouse gas emissions with production in the United States compared with China,” Keoleian added.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
By
Investing

US Cancels US$500 Million Cobalt Tender in Setback for Critical Minerals Strategy

The US Department of Defense has canceled its long-awaited plan to buy up to US$500 million worth of cobalt, a mineral vital to electric vehicles, jet engines and advanced weapons systems.

The Defense Logistics Agency (DLA) confirmed the cancellation in a notice published Wednesday (October 15), saying there are “outstanding issues with the Statement of Work that need resolution before offers may be solicited.”

The decision comes after months of delays and moving deadlines. The agency added that the solicitation will be “re-issued with a new opening and closing date” once the matter is resolved.

The DLA first issued the tender in mid-August, seeking bids for up to 7,500 metric tons of alloy-grade cobalt over the next five years, with spending ranging from US$2 million to a maximum ofUS $500 million.

The offer window, which was initially due to close on August 29, was extended several times, ultimately to Wednesday.

The abrupt cancellation is being viewed as a setback to the American government’s ongoing strategy of stockpiling domestic supplies, especially as western nations race to reduce reliance on China for raw materials.

Cobalt plays a central role in rechargeable batteries used in electric vehicles and consumer electronics, as well as in the high-temperature alloys that power jet engines and industrial gas turbines.

The metal also has defense applications, including in precision munitions and magnetic systems.

Currently, China dominates the processing of cobalt and has built a significant state stockpile, while the Democratic Republic of Congo (DRC) produces roughly three-quarters of the world’s supply.

The cobalt market has also seen shifting volatility. In recent months, prices have doubled following export restrictions from the DRC, which initially banned shipments outright before shifting to a quota system.

Benchmark prices had languished below US$10 a pound earlier this year — levels not seen in over two decades — before surging as traders scrambled to adjust to the new policy.

The DLA had restricted its call for offers to three major suppliers: Vale’s (NYSE:VALE) operations in Canada, Sumitomo (OTC Pink:SSUMF,TSE:8053) in Japan, and Glencore’s (LSE:GLEN,OTC Pink:GLCNF) Nikkelverk refinery in Norway.

In April, US President Donald Trump invoked emergency powers to spur domestic production of critical minerals, part of a broader plan to reduce foreign dependence and strengthen national security.

The White House has also created a National Security Council office led by former mining executive David Copley to coordinate supply chain strategy across agencies.

The push to secure materials like cobalt, lithium and rare earth elements has taken on greater urgency as the US-China trade war ramps up, with China tightening export restrictions on rare earths last week.

Despite the suspension of efforts, officials insist the cobalt project is not abandoned. The DLA affirmed that solicitation is expected to be reopened with updated terms once it resolves its contracting issues.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
By
Investing

CSE Bulletin: MOC Eligibility Update

The following CSE-Listed symbol will become MOC Eligible as detailed below.

Symbol Company Name Effective Date
AIML AI/ML Innovations Inc. Wednesday October 22, 2025
ARGO Argo Graphene Solutions Corp.
CUPR Super Copper Corp.
DATT Digital Asset Technologies Inc.
GXP Greenridge Exploration Inc.
ISP Inspiration Energy Corp.
QMET Q Precious & Battery Metals Corp.
SYAI Syntheia Corp.
WG Westward Gold Inc.

 
The full list of MOC-Eligible symbols is available at https://thecse.com/trading/trading-resources/#market-on-close.

For further information, please contact CSE Market Operations at Marketops@thecse.com or 416-306-0772.

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
By
Investing

Vince Lanci: Silver’s London Liquidity Crisis — What’s Happening, What’s Next

Vince Lanci of Echobay Partners explains what’s driving silver’s record-setting price run.

According to Lanci, who is also a professor at the University of Connecticut and publisher of the GoldFix newsletter on Substack, the London market is facing a liquidity crisis as nations that would typically sell or lend their silver choose to keep the metal at home.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
By
Investing

Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027

  • MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.

  • New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025.

  • Next-generation therapy CRD-38 for heart failure funded through to clinical development, with partnership discussions advancing with leading pharmaceutical companies.

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company advancing late-stage, anti-inflammatory and anti-fibrotic therapies for heart disease, today announced the successful completion of a private placement offering (the ‘Offering’) of units (‘Units’) for net proceeds of US$11 million. The initial closing of US$10 million has been completed, with the remaining US$1 million to close on Monday, October 20, 2025.

‘As recruitment in our pivotal Phase III MAVERIC trial gains momentum, with several prominent centers across the U.S. now enrolling patients, we are pleased to have secured a direct investment of US$11 million to strengthen our balance sheet and accelerate the development of our novel heart failure drug, CRD-38, based on the recently reported findings from our ARCHER trial,’ said David Elsley, President and CEO of Cardiol Therapeutics. ‘Topline results from our ARCHER trial demonstrated a significant reduction in LV mass-marking the first evidence of structural and remodeling improvement in patients with myocarditis. This landmark finding represents our second clinical validation in inflammatory heart disease and establishes a key translational link to data published earlier this year in the Journal of the American College of Cardiology, which demonstrated the beneficial effects of the active pharmaceutical ingredient or API in CardiolRx on cardiac structure, inflammation, and fibrosis in a model of heart failure. The ARCHER findings support pursuing an additional Orphan Drug Designation for CardiolRx in myocarditis and advancing the development of our next-generation CRD-38 formulation, which delivers the same API via subcutaneous administration, to target the broader heart failure market. Notably, blockbuster drugs that reduce LV mass have been shown to lower heart failure-related death and hospitalization, underscoring the clinical potential of Cardiol’s differentiated anti-inflammatory mechanism to address a large unmet need in heart failure, where five-year mortality rates still exceed 50%.’

Under the Offering, the Company sold a total of 11 million Units at a price of US$1.00 per Unit. Each Unit consists of one Class A common share of the Company (a ‘Common Share‘) and one-half of one Common Share purchase warrant. Each whole warrant entitles the holder to acquire one additional Common Share at an exercise price of US$1.35 for a period of 24 months from the date of issuance. The warrants include an acceleration provision, allowing the Company to advance their expiry to the 30th day following the issuance of a news release if the daily volume-weighted average trading price of the Common Shares exceeds US$2.00 for five consecutive trading days. Proceeds from the Offering provide cash resources that are anticipated to support operations into the third quarter of 2027.

The securities have not been registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any U.S. state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the ‘United States’ or ‘U.S. persons’ (as such terms are used in Regulation S under the U.S. Securities Act), absent registration under the U.S. Securities Act and all applicable U.S. state securities laws or in compliance with an exemption therefrom. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Certain insiders of the Company participated in the Offering. Such participation is considered to be a ‘related-party transaction’ within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (‘MI 61-101‘). The Company is relying on the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of related-party participation in the Offering as the fair market value (as determined under MI 61-101) of the subject matter of, and the fair market value of the consideration for, the transaction, insofar as it involved interested parties, did not exceed 25% of the Company’s market capitalization (as determined under MI 61-101).

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company advancing late-stage, anti-inflammatory and anti-fibrotic therapies for heart disease. The Company’s lead small molecule drug candidate, CardiolRx, modulates inflammasome pathway activation, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with pericarditis, myocarditis, and heart failure.

The MAVERIC Program in recurrent pericarditis, an inflammatory disease of the pericardium which is associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, and results in physical limitations, reduced quality of life, emergency department visits, and hospitalizations, comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing pivotal Phase III MAVERIC trial (NCT06708299). The U.S. FDA has granted Orphan Drug Designation to CardiolRx for the treatment of pericarditis, which includes recurrent pericarditis.

The ARCHER Program (NCT05180240) comprises the completed Phase II study in acute myocarditis, an important cause of acute and fulminant heart failure in young adults and a leading cause of sudden cardiac death in people less than 35 years of age.

Cardiol is also developing CRD-38, a novel subcutaneously administered drug formulation intended for use in heart failure-a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding US$30 billion annually.

For more information about Cardiol Therapeutics, please visit cardiolrx.com.

Cautionary statement regarding forward-looking information:

This news release contains ‘forward-looking information’ within the meaning of applicable securities laws. All statements, other than statements of historical fact, that address activities, events, or developments that Cardiol believes, expects, or anticipates will, may, could, or might occur in the future are ‘forward-looking information’. Forward-looking information contained herein may include, but is not limited to statements regarding the Company’s focus on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, the Company’s intended clinical studies and trial activities and timelines associated with such activities, including the Company’s plan to complete the Phase III study in recurrent pericarditis with CardiolRx, the Company’s plan to advance the development of CRD-38, a novel subcutaneous formulation intended for use in heart failure, the Company’s presentation and publication of the comprehensive ARCHER trial data, the Company’s belief that results from the ARCHER trial provide compelling clinical proof of concept for CardiolRx and strongly support advancing the clinical development of CardiolRx and CRD-38 for the treatment of inflammatory cardiac disorders including cardiomyopathies, heart failure, and myocarditis, and statements regarding the expected length and scope of funding for the Company’s development plans as a result of the Offering. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is based on certain assumptions and is also subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance or achievements expressed or implied by the forward looking information, and are not (and should not be considered to be) guarantees of future performance. These risks and uncertainties and other factors include the risks and uncertainties referred to in the Company’s Annual Information Form filed with the Canadian securities administrators and U.S. Securities and Exchange Commission on March 31, 2025, available on SEDAR+ at sedarplus.ca and EDGAR at sec.gov, as well as the risks and uncertainties associated with product commercialization and clinical studies. These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information, and such information may not be appropriate for other purposes. Any forward-looking information speaks only as of the date of this press release and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events, or results, or otherwise. Investors are cautioned not to rely on these forward-looking statements.

For further information, please contact:
Trevor Burns, Investor Relations +1-289-910-0855
trevor.burns@cardiolrx.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270946

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
By
Investing

Top 5 Canadian Mining Stocks This Week: JZR Gold Jumps 113 Percent

The Government of Ontario started taking applications for resource development projects under its “One Project, One Process” framework on Friday (October 17).

The new process, which Ontario lawmakers introduced in the spring, promises to streamline and reduce the permitting time for selected projects by at least half, introducing a dedicated office to consolidate applications. Under the current system, the permitting process can add up to 15 years to a project’s development cycle, the government stated.

In addition to supporting Ontario’s mining industry, the new framework is also a reaction to policy shifts in the United States under the Trump administration, as his tariff policy affects the Ontario and Canadian economies.

“With President Trump taking direct aim at our economy, it has never been more important to protect Ontario jobs and build the mines that will power our future,” said Stephen Lecce, Minister of Energy and Mines.

The new policy is similar to the national one introduced by Prime Minister Mark Carney in September. That program, which created the Major Projects Office, is geared to support investment and permitting for projects deemed to be in the national interest. The initiative was part of his election platform earlier in the year in response to Trump’s tariffs on imports of Canadian goods.

In a speech to the Peterson Institute of International Economics on Thursday (October 16), Bank of Canada Governor Tiff Macklem stated that Canada’s growth outlook remains “soft.”

He identified several trends that are affecting Canadian and global economies. The first is a slowing of global trade that began in 2010, which then accelerated as Trump increased tariff rates to the highest levels since the 1930s.

The second is a shift away from the US as the world’s largest trading hub, as supply chains strengthen in China and Europe, creating new hubs there. Macklem also noted that, while the US remains dominant in global finance, investors have expressed uncertainty due to its declining trade position and increasing debt load.

For Canada, Macklem said the tariffs have affected cross-border trade and stymied investment into Canadian industries, weakening gross domestic product growth.

Although it’s uncertain if the Bank of Canada will cut its rate when it makes its next policy decision on October 29, Macklem said, “Monetary policy cannot undo the damage of tariffs.” Instead, he suggested that Canada needs to lower barriers to interprovincial trade and focus on projects that increase the export of Canadian goods overseas.

South of the border, Federal Reserve Chairman Jerome Powell gave a speech on Tuesday (October 14) to the National Association of Business Economics in Philadelphia. In his remarks, he said the outlook for the jobs market and inflation has not changed since September, and signaled the likelihood of another rate cut when the Federal Open Market Committee meets on October 28 and 29.

In the days following Powell’s remarks, the price of gold surged to a new record high of US$4,379.13 on Thursday, and silver rose to a new record of US$54.40 per ounce. Both have since retreated, but remain elevated.

For more on what’s moving markets this week, check out our top market news round-up.

Markets and commodities react

Canadian equity markets were down this week.

The S&P/TSX Composite Index (INDEXTSI:OSPTX) lost 0.71 percent over the week to close Friday at 30,108.48.

The S&P/TSX Venture Composite Index (INDEXTSI:JX) fared worse, ending the week down 3.85 percent at 965.58. The CSE Composite Index (CSE:CSECOMP) also fell this week, shedding 5.33 percent to close out the week at 179.76.

The gold price set another new record, reaching an intraday high of US$4,379.13 per ounce in early morning trading Friday EST before retreating to US$4,252.69 by Friday’s close. Ultimately, gold was up 5.82 percent over the week.

The silver price also gained significantly this week, again breaking its own all-time high in early trading Friday when it reached US$54.47 per ounce. However, it had pulled back US$51.76 by 4:00 p.m. EDT Friday, posting a weekly gain of 3.46 percent.

The copper price was flat on the week, down just 0.2 percent to US$5.03 per pound.

The S&P Goldman Sachs Commodities Index (INDEXSP:SPGSCI) fell 2.23 percent to end Friday at 539.84.

Top Canadian mining stocks this week

How did mining stocks perform against this backdrop?

Take a look at this week’s five best-performing Canadian mining stocks below.

Stocks data for this article was retrieved at 4:00 p.m. EDT on Friday using TradingView’s stock screener. Only companies trading on the TSX, TSXV and CSE with market caps greater than C$10 million are included. Mineral companies within the non-energy minerals, energy minerals, process industry and producer manufacturing sectors were considered.

1. JZR Gold (TSXV:JZR)

Weekly gain: 112.77 percent
Market cap: C$28.95 million
Share price: C$0.50

JZR Gold is a gold company with exposure to the Vila Nova gold project, located in Amapá, Brazil, through a joint venture royalty agreement with the project’s operator, ECO Mining Oil & Gaz Drilling and Exploration.

JZR received a 50 percent net profit interest in the Vila Nova project following the completion of payments totaling US$6 million to ECO in January 2023. The funds were used to advance the project and construct an 800 metric ton per day bulk sampling gravimetric mill at the site.

According to JZR, the funding is considered a loan and will be “repaid to the Company from the proceeds of the sale of any products, prior to the distribution of any profits.”

The project holds approximately 9 million metric tons of gold tailings grading an average of 2.47 grams per metric ton (g/t) gold from historic operations. The companies plan to reprocess the tailings to generate near-term cash flow that will fund further exploration at the site, anticipating production of 2 kilograms of gold per day.

Shares gained this week alongside the October 14 news that ECO produced the first gold concentrate from the Vila Nova gold project’s mill. JZR said that ECO has begun to stockpile material at the mill site as it continues testing and optimization, with the goal of improving efficiency and increasing throughput.

2. Austral Gold (TSXV:AGLD)

Weekly gain: 90 percent
Market cap: C$75.37 million
Share price: C$0.095

Austral Gold is a gold production company operating two mines in Latin America.

Its Guanaco – Amancaya mine complex in Chile is its primary operation, hosting a 1,500 metric ton per day milling circuit, a 3,000 metric ton per day crushing circuit and a heap leaching processing plant. In 2024, the complex produced 15,138 ounces of gold and 37,154 ounces of silver.

Austral’s other operation is the Casposo – Manantiales complex in Argentina, which hosts a 1,100 metric ton per day mill and a dry-stack tailings facility. The mine had been on care and maintenance since 2019, during which time Austral worked on exploration at the site, along with its refurbishment plan to restart operations.

Shares in Austral rose this week following a pair of announcements on Tuesday.

The first was a report that Austral has resumed production at Casposo, currently sourcing material from the existing stockpiles. The company said it plans to transition to open-pit mining and is in negotiations with a contractor to finalize an agreement.

The company produced 230 gold equivalent ounces of doré during the commissioning phase, which began in December 2024, according to the release. It expects Casposo to produce 4,000 to 6,000 gold equivalent ounces during Q4.

In the other release, Austral provided an updated mineral reserve estimate for Casposo reporting proven and probable gold contained to be 80,000 ounces of gold and 3.28 million ounces of silver with average grades of 1.31 g/t gold and 58.52 g/t silver from 2.15 million metric tons of ore.

3. Resouro Strategic Metals (TSXV:RSM)

Weekly gain: 88.64 percent
Market cap: C$29.14 million
Share price: C$0.415

Resouro Strategic Metals is a polymetallic exploration and development company working to advance its mineral properties in Brazil.

Its Tiros rare earth metals and titanium project is located in Minas Gerais, Brazil, and comprises 28 mineral rights covering an area of 497 square kilometers.

According to a May 2025 technical report, the site hosts a measured and indicated resource of 1.4 billion metric tons of ore grading 12 percent titanium dioxide and 4,000 parts per million of total rare earth content.

The company also owns the Novo Mundo gold project located in the Alta Floresta gold province in Central Brazil. It consists of three licenses totaling 167 square kilometers.

On Tuesday, Resouro provided an update to its ongoing private placement, noting that it had received subscription agreements and expects to close in the next week.

4. Nio Strategic Metals (TSXV:NIO)

Weekly gain: 75 percent
Market cap: C$16.24 million
Share price: C$0.175

Nio Strategic Metals is an exploration company working to advance its assets in Québec, Canada.

Its primary focus has been on its Oka rare earth and critical minerals project. The property hosts a past-producing niobium mine and several nearby mineralized zones.

According to the project page, Oka’s total measured and indicated resource is 10.63 million metric tons of ore at an average grade of 0.65 percent niobium oxide.

While the company did not release any news this week, shares in Nio Strategic Metals rose significantly.

5. Boron One (TSXV:BONE)

Weekly gain: 71 percent
Market cap: C$14.92 million
Share price: C$0.06

Boron One is an exploration company focused on advancing its Piskanja project located near Belgrade, Serbia.

The asset hosts two primary densely mineralized zones with gently undulating borate beds. The company was initially granted its exploration license in 2010, with the exclusive right to apply for a mining license.

In a preliminary economic assessment for the project released in June 2022, Boron One, then named Erin Ventures, reported an economic case with an after-tax, net present value of US$524.9 million with an internal rate of return of 78.7 percent and a payback period of 12 months.

It also provided a mineral resource statement that demonstrated a measured and indicated resource of 2.36 million metric tons of boric oxide from 6.87 million metric tons of ore with an average grade of 34.36 percent boric oxide.

The most recent news from the project came on September 26 when the company provided an update on its application for a mining license, noting the Ministry of Mining has requested amendments to the company’s application before it can be approved.

Boron One said it is preparing the revised version “as quickly as possible.”

FAQs for Canadian mining stocks

What is the difference between the TSX and TSXV?

The TSX, or Toronto Stock Exchange, is used by senior companies with larger market caps, and the TSXV, or TSX Venture Exchange, is used by smaller-cap companies. Companies listed on the TSXV can graduate to the senior exchange.

How many mining companies are listed on the TSX and TSXV?

As of May 2025, there were 1,565 companies listed on the TSXV, 910 of which were mining companies. Comparatively, the TSX was home to 1,899 companies, with 181 of those being mining companies.

Together, the TSX and TSXV host around 40 percent of the world’s public mining companies.

How much does it cost to list on the TSXV?

There are a variety of different fees that companies must pay to list on the TSXV, and according to the exchange, they can vary based on the transaction’s nature and complexity. The listing fee alone will most likely cost between C$10,000 to C$70,000. Accounting and auditing fees could rack up between C$25,000 and C$100,000, while legal fees are expected to be over C$75,000 and an underwriters’ commission may hit up to 12 percent.

The exchange lists a handful of other fees and expenses companies can expect, including but not limited to security commission and transfer agency fees, investor relations costs and director and officer liability insurance.

These are all just for the initial listing, of course. There are ongoing expenses once companies are trading, such as sustaining fees and additional listing fees, plus the costs associated with filing regular reports.

How do you trade on the TSXV?

Investors can trade on the TSXV the way they would trade stocks on any exchange. This means they can use a stock broker or an individual investment account to buy and sell shares of TSXV-listed companies during the exchange’s trading hours.

Article by Dean Belder; FAQs by Lauren Kelly.

Securities Disclosure: I, Dean Belder, hold no direct investment interest in any company mentioned in this article.

Securities Disclosure: I, Lauren Kelly, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
By
Investing

Tech Weekly: Broadcom and OpenAI Sign Deal, AMD and Oracle Announce Partnership

This week was marked by strong, event-driven volatility across the tech sector.

Market moves were shaped by artificial intelligence (AI) infrastructure announcements, semiconductor earnings, signals of macroeconomic stress and escalating tensions between the US and China.

Effects of the US government shutdown, coupled with renewed trade tensions between the world’s largest tech markets, weighed on global equities. Quarterly results from regional banks eased earlier concerns about credit risks after Zions Bancorp (NASDAQ:ZION) and Western Alliance (NYSE:WAL) disclosed loan issues related to apparent fraud.

Wall Street ultimately saw weekly gains, despite a midweek selloff that impacted high-value, high-risk sectors.

Hardware and infrastructure were the core positive contributors in the tech sector, reflecting the ongoing AI supercycle investment theme fueled by chip production and data center buildouts.

Semiconductor stocks were the standout performers, boosted by record earnings reports from Taiwan Semiconductor Manufacturing Company (TSMC) (NYSE:TSM) on Tuesday (October 14) and ASML Holding (NASDAQ:ASML) on Wednesday (October 15). Broadcom (NASDAQ:AVGO) and NVIDIA (NASDAQ:NVDA) also rose alongside TSMC, contributing to PHLX Semiconductor Sector’s (INDEXNASDAQ:SOX) 1.2 percent rebound on Thursday (October 16).

Advanced Micro Devices’ (NASDAQ:AMD) deal with Oracle (NYSE:ORCL) to deploy 50,000 GPUs, which was announced the same day as TSMC’s earnings, added a competitive dynamic that sparked selective volatility among chipmakers; at the same time, it underscored strong AI-driven hardware demand across the sector.

In consumer hardware, Apple’s (NASDAQ:AAPL) product launch was notable, but not the primary market mover.

Data centers also had a big impact, highlighted by Microsoft’s (NASDAQ:MSFT) US$14 billion Texas AI data center partnership with Nscale, and Brookfield Asset Management’s (TSX:BAM,NYSE:BAM) US$5 billion investment in Bloom Energy’s (NYSE:BE) fuel cell technology for powering AI-focused data centers. Oracle is forecasting acceleration in its AI data center business, indicating expanding hardware-backed infrastructure demand

Software and cloud-native company movements were more mixed, with gains from Salesforce (NYSE:CRM), but declines from others like Meta Platforms (NASDAQ:META) and Palantir Technologies (NASDAQ:PLTR).

3 tech stocks that moved markets this week

1. Broadcom (NASDAQ:AVGO)

Broadcom shares surged nearly 10 percent on Monday (October 13) after OpenAI announced a multi-year agreement to co-develop custom AI GPUs. The collaboration will focus on deploying 10 gigawatts of custom AI accelerators designed by OpenAI and built by Broadcom, with deployment set to start in H2 2026 and continue through 2029.

Later, multiple reports emerged citing individuals claiming that OpenAI is also partnering with Arm Holdings (NASDAQ:ARM) to produce custom CPUs to work alongside its Broadcom co-designed chip.

Shares of Arm also advanced by over 11 percent.

2. Advanced Micro Devices (NASDAQ:AMD)

Oracle and AMD also announced a major partnership this week, where Oracle will deploy 50,000 AMD-powered MI450 GPUs in its cloud infrastructure starting in the third quarter of 2026, with plans for ongoing expansion.

AMD’s share price rose by over 9 percent on the news, with the deal creating competitive pressure for rival chipmakers like NVIDIA. Meanwhile, Oracle shares declined by almost 7 percent on Friday (October 17) after the firm’s CEO, Clay Magouryk, provided an upbeat projection to analysts, indicating that the deployment of 50,000 AMD-powered MI450 GPUs will significantly accelerate Oracle’s AI business growth.

However, analysts highlighted the potential for a significantly high CAPEX, possibly leading to negative free cashflow totaling more than US$26 billion over the next three fiscal years.

3. Salesforce (NYSE:CRM)

Shares of Salesforce rose by almost 4 percent on Thursday after the company announced a revenue target of US$60 billion by 2030 during its Investor Day at Dreamforce event on Wednesday.

Salesforce plans to achieve this ambitious target through accelerated adoption of AI-powered cloud platforms and ongoing innovation in enterprise software services, as well as expanded use of generative AI across its CRM, analytics, and automation suites.

Broadcom, Salesforce and AMD performance, October 14 to 17, 2025.

Chart via Google Finance.

Tech ETF performance

This week, the iShares Semiconductor ETF (NASDAQ:SOXX) advanced by 1.94 percent, while the Invesco PHLX Semiconductor ETF (NASDAQ:SOXQ) saw a weekly gain of 1.66 percent.

The VanEck Semiconductor ETF (NASDAQ:SMH) increased by 1.59 percent.

These modest gains occurred against a backdrop of heightened volatility, indicating ongoing optimism in the long-term growth of the semiconductor industry.

Other tech market news

            Tech news to watch next week

            Next week brings quarterly earnings from major tech firms Tesla (NASDAQ:TSLA) and IBM (NYSE:IBM) on October 22, followed by Intel (NASDAQ:INTC) and Amazon (NASDAQ:AMZN) on October 23.

            Any new developments in US-China relations, potential technology export restrictions or antitrust actions could significantly affect tech stock performance. Market watchers will also be on the lookout for any indication of an end to the US government shutdown.

            Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

            This post appeared first on investingnews.com

            Keep Reading
            By